Drug
Ccx 354 C
Ccx 354 C: highest development phase Phase 1/2, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| CCX 354-C NCT01027728 | Phase 1/2 | Rheumatoid Arthritis |
Latest
No recent events.
Follow Ccx 354 C on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.